Quantcast

Coronary Artery Disease (Ischemic Heart Disease) Therapeutic Analysis in New Research Report at ReportsnReports.com

December 30, 2012

ReportsnReports.com adds “Coronary Artery Disease (CAD) (Ischemic Heart Disease) — Pipeline Review, H2 2012” new market research report to its store.

Dallas, TX (PRWEB) December 30, 2012

”Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H2 2012”, provides an overview of the indication´s therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease). Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct´s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct´s team.

Scope of “Coronary Artery Disease (CAD) (Ischemic Heart Disease) — Pipeline Review, H2 2012”

  • A snapshot of the global therapeutic scenario for Coronary Artery Disease (CAD) (Ischemic Heart Disease).
  • A review of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=211519

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Coronary Artery Disease (CAD) (Ischemic Heart Disease).
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Browse more reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/

About Us:

ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebcoronary-artery-disease/ischemic-heart-disease/prweb10277647.htm


Source: prweb



comments powered by Disqus